Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Atul B. Shinagare, M.D.

Co-Author

This page shows the publications co-authored by Atul Shinagare and Katherine Krajewski.
Connection Strength

5.981
  1. Molecular Targeted Therapy in Modern Oncology: Imaging Assessment of Treatment Response and Toxicities. Korean J Radiol. 2017 Jan-Feb; 18(1):28-41.
    View in: PubMed
    Score: 0.730
  2. Novel imaging in renal cell carcinoma. Curr Opin Urol. 2016 09; 26(5):388-95.
    View in: PubMed
    Score: 0.713
  3. A review of the principles of texture analysis and its role in imaging of genitourinary neoplasms. Abdom Radiol (NY). 2019 07; 44(7):2501-2510.
    View in: PubMed
    Score: 0.217
  4. Radiogenomics in renal cell carcinoma. Abdom Radiol (NY). 2019 06; 44(6):1990-1998.
    View in: PubMed
    Score: 0.216
  5. Updates for the radiologist in non-muscle-invasive, muscle-invasive, and metastatic bladder cancer. Abdom Radiol (NY). 2017 11; 42(11):2710-2724.
    View in: PubMed
    Score: 0.193
  6. Advanced Renal Cell Carcinoma: Role of the Radiologist in the Era of Precision Medicine. Radiology. 2017 08; 284(2):333-351.
    View in: PubMed
    Score: 0.190
  7. Cancer Imaging Fellowship Training: Utility and Added Value in the Modern Era. J Am Coll Radiol. 2017 10; 14(10):1345-1348.
    View in: PubMed
    Score: 0.189
  8. T-Cell Non-Hodgkin Lymphomas: Spectrum of Disease and the Role of Imaging in the Management of Common Subtypes. Korean J Radiol. 2017 Jan-Feb; 18(1):71-83.
    View in: PubMed
    Score: 0.183
  9. Update on Radiogenomics of Clear Cell Renal Cell Carcinoma. Eur Urol Focus. 2016 Dec 15; 2(6):572-573.
    View in: PubMed
    Score: 0.182
  10. Multimodality imaging of locally recurrent and metastatic cervical cancer: emphasis on histology, prognosis, and management. Abdom Radiol (NY). 2016 12; 41(12):2496-2508.
    View in: PubMed
    Score: 0.181
  11. Impact of histologic subtype and sarcomatoid transformation on metastasis in renal cell carcinoma: a single institute experience in 149 patients. Abdom Radiol (NY). 2016 Feb; 41(2):295-302.
    View in: PubMed
    Score: 0.171
  12. Metastatic Chordoma: Report of the Two Cases and Review of the Literature. Eurasian J Med. 2015 Jun; 47(2):151-4.
    View in: PubMed
    Score: 0.163
  13. Update on the role of imaging in management of metastatic colorectal cancer. Radiographics. 2014 Nov-Dec; 34(7):1908-28.
    View in: PubMed
    Score: 0.157
  14. Malignant skin and subcutaneous neoplasms in adults: multimodality imaging with CT, MRI, and 18F-FDG PET/CT. AJR Am J Roentgenol. 2014 May; 202(5):W422-38.
    View in: PubMed
    Score: 0.152
  15. Liver metastases in the era of molecular targeted therapy: new faces of treatment response. AJR Am J Roentgenol. 2013 Jul; 201(1):W15-28.
    View in: PubMed
    Score: 0.143
  16. MRI for evaluation of myeloid sarcoma in adults: a single-institution 10-year experience. AJR Am J Roentgenol. 2012 Dec; 199(6):1193-8.
    View in: PubMed
    Score: 0.137
  17. Pneumatosis intestinalis and bowel perforation associated with molecular targeted therapy: an emerging problem and the role of radiologists in its management. AJR Am J Roentgenol. 2012 Dec; 199(6):1259-65.
    View in: PubMed
    Score: 0.137
  18. Genitourinary imaging: part 2, role of imaging in medical management of advanced renal cell carcinoma. AJR Am J Roentgenol. 2012 Nov; 199(5):W554-64.
    View in: PubMed
    Score: 0.137
  19. Esophageal gastrointestinal stromal tumor: report of 7 patients. Cancer Imaging. 2012 Apr 27; 12:100-8.
    View in: PubMed
    Score: 0.132
  20. A to Z of desmoid tumors. AJR Am J Roentgenol. 2011 Dec; 197(6):W1008-14.
    View in: PubMed
    Score: 0.128
  21. Incidence of pulmonary embolism in oncologic outpatients at a tertiary cancer center. Cancer. 2011 Aug 15; 117(16):3860-6.
    View in: PubMed
    Score: 0.121
  22. A cost-effectiveness analysis of the diagnostic strategies for differentiating focal nodular hyperplasia from hepatocellular adenoma. Eur Radiol. 2018 Jan; 28(1):214-225.
    View in: PubMed
    Score: 0.047
  23. Imaging of hepatic toxicity of systemic therapy in a tertiary cancer centre: chemotherapy, haematopoietic stem cell transplantation, molecular targeted therapies, and immune checkpoint inhibitors. Clin Radiol. 2017 Jul; 72(7):521-533.
    View in: PubMed
    Score: 0.047
  24. Role of Imaging in Management of Desmoid-type Fibromatosis: A Primer for Radiologists. Radiographics. 2016 May-Jun; 36(3):767-82.
    View in: PubMed
    Score: 0.044
  25. A New Look at Toxicity in the Era of Precision Oncology: Imaging Findings, Their Relationship With Tumor Response, and Effect on Metastasectomy. AJR Am J Roentgenol. 2016 Jul; 207(1):4-14.
    View in: PubMed
    Score: 0.043
  26. Multimodality imaging of osseous involvement In haematological malignancies. Br J Radiol. 2016; 89(1059):20150980.
    View in: PubMed
    Score: 0.043
  27. Imaging of Fluid in Cancer Patients Treated With Systemic Therapy: Chemotherapy, Molecular Targeted Therapy, and Hematopoietic Stem Cell Transplantation. AJR Am J Roentgenol. 2015 Oct; 205(4):709-19.
    View in: PubMed
    Score: 0.042
  28. Extracutaneous melanomas: a primer for the radiologist. Insights Imaging. 2015 Dec; 6(6):707-17.
    View in: PubMed
    Score: 0.042
  29. Imaging of Nervous System Involvement in Hematologic Malignancies: What Radiologists Need to Know. AJR Am J Roentgenol. 2015 Sep; 205(3):604-17.
    View in: PubMed
    Score: 0.042
  30. MDCT and clinicopathological features of small bowel gastrointestinal stromal tumours in 102 patients: a single institute experience. Br J Radiol. 2015 Sep; 88(1053):20150085.
    View in: PubMed
    Score: 0.041
  31. Hormonal therapy in oncology: a primer for the radiologist. AJR Am J Roentgenol. 2015 Jun; 204(6):W620-30.
    View in: PubMed
    Score: 0.041
  32. Beyond the vascular endothelial growth factor axis: update on role of imaging in nonantiangiogenic molecular targeted therapies in oncology. AJR Am J Roentgenol. 2015 May; 204(5):919-32.
    View in: PubMed
    Score: 0.041
  33. Esophageal Carcinoma: Current Concepts in the Role of Imaging in Staging and Management. Can Assoc Radiol J. 2015 May; 66(2):130-9.
    View in: PubMed
    Score: 0.040
  34. Anti-VEGF molecular targeted therapies in common solid malignancies: comprehensive update for radiologists. Radiographics. 2015 Mar-Apr; 35(2):455-74.
    View in: PubMed
    Score: 0.040
  35. Fluid retention associated with imatinib treatment in patients with gastrointestinal stromal tumor: quantitative radiologic assessment and implications for management. Korean J Radiol. 2015 Mar-Apr; 16(2):304-13.
    View in: PubMed
    Score: 0.040
  36. Clinical and radiologic features of extraskeletal myxoid chondrosarcoma including initial presentation, local recurrence, and metastases. Radiol Oncol. 2014 Sep; 48(3):235-42.
    View in: PubMed
    Score: 0.038
  37. MRI features of extramedullary myeloma. AJR Am J Roentgenol. 2014 Apr; 202(4):803-10.
    View in: PubMed
    Score: 0.038
  38. Imaging of uncommon esophageal malignancies. Dis Esophagus. 2015 Aug-Sep; 28(6):552-9.
    View in: PubMed
    Score: 0.038
  39. Multidetector-row CT of tumour-bowel fistula: Experience at a tertiary cancer centre. Clin Radiol. 2014 Feb; 69(2):e100-7.
    View in: PubMed
    Score: 0.037
  40. Radiologic assessment of earliest, best, and plateau response of gastrointestinal stromal tumors to neoadjuvant imatinib prior to successful surgical resection. Eur J Surg Oncol. 2014 Apr; 40(4):420-8.
    View in: PubMed
    Score: 0.037
  41. Gallbladder complications associated with molecular targeted therapies: clinical and imaging features. Clin Imaging. 2014 Jan-Feb; 38(1):50-5.
    View in: PubMed
    Score: 0.036
  42. Imatinib and beyond in gastrointestinal stromal tumors: A radiologist's perspective. AJR Am J Roentgenol. 2013 Oct; 201(4):801-10.
    View in: PubMed
    Score: 0.036
  43. Update on the management of gastroenteropancreatic neuroendocrine tumors with emphasis on the role of imaging. AJR Am J Roentgenol. 2013 Oct; 201(4):811-24.
    View in: PubMed
    Score: 0.036
  44. Acute pancreatitis associated with molecular targeted therapies: a retrospective review of the clinico-radiological features, management and outcome. Pancreatology. 2013 Sep-Oct; 13(5):461-7.
    View in: PubMed
    Score: 0.036
  45. Anal carcinoma: FDG PET/CT in staging, response evaluation, and follow-up. Abdom Imaging. 2013 Aug; 38(4):728-35.
    View in: PubMed
    Score: 0.036
  46. Intrathoracic malignant peripheral nerve sheath tumors: imaging features and implications for management. Radiol Oncol. 2013; 47(3):230-8.
    View in: PubMed
    Score: 0.036
  47. Update on imaging of vulvar squamous cell carcinoma. AJR Am J Roentgenol. 2013 Jul; 201(1):W147-57.
    View in: PubMed
    Score: 0.036
  48. Merkel cell carcinoma: a primer for the radiologist. AJR Am J Roentgenol. 2013 Jun; 200(6):1186-96.
    View in: PubMed
    Score: 0.036
  49. Molecular targeted therapies in non-GIST soft tissue sarcomas: what the radiologist needs to know. Cancer Imaging. 2013 May 02; 13:197-211.
    View in: PubMed
    Score: 0.035
  50. Ipilimumab-associated colitis: CT findings. AJR Am J Roentgenol. 2013 May; 200(5):W468-74.
    View in: PubMed
    Score: 0.035
  51. Cancer of unknown primary sites: what radiologists need to know and what oncologists want to know. AJR Am J Roentgenol. 2013 Mar; 200(3):484-92.
    View in: PubMed
    Score: 0.035
  52. Imaging features of primary anorectal gastrointestinal stromal tumors with clinical and pathologic correlation. Cancer Imaging. 2013 Feb 08; 12:557-65.
    View in: PubMed
    Score: 0.035
  53. Malignant peripheral nerve sheath tumors: prognostic impact of rhabdomyoblastic differentiation (malignant triton tumors), neurofibromatosis 1 status and location. Eur J Surg Oncol. 2013 Jan; 39(1):46-52.
    View in: PubMed
    Score: 0.034
  54. Imaging features of primary extranodal histiocytic sarcoma: report of two cases and a review of the literature. Cancer Imaging. 2012 Aug 10; 12:253-8.
    View in: PubMed
    Score: 0.034
  55. Synovial sarcoma: imaging features of common and uncommon primary sites, metastatic patterns, and treatment response. AJR Am J Roentgenol. 2012 Aug; 199(2):W208-15.
    View in: PubMed
    Score: 0.034
  56. What the emergency radiologist needs to know about treatment-related complications from conventional chemotherapy and newer molecular targeted agents. Emerg Radiol. 2012 Dec; 19(6):535-46.
    View in: PubMed
    Score: 0.033
  57. Imaging features of bowel toxicities in the setting of molecular targeted therapies in cancer patients. Br J Radiol. 2012 Oct; 85(1018):1420-6.
    View in: PubMed
    Score: 0.033
  58. Extrahepatic spread of hepatocellular carcinoma: spectrum of imaging findings. AJR Am J Roentgenol. 2011 Oct; 197(4):W658-64.
    View in: PubMed
    Score: 0.032
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.